ACY3 | Aspartoacylase (aminocyclase) 3 | Enzymes
| | | | | Tissue enhanced |
AGMAT | Agmatine ureohydrolase (agmatinase) | Enzymes Mitochondrial proteins
| | | | | Tissue enhanced |
AIF1L | Allograft inflammatory factor 1-like | | | | | | Tissue enhanced |
AK4 | Adenylate kinase 4 | Enzymes Mitochondrial proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ALDH1L1 | Aldehyde dehydrogenase 1 family, member L1 | Enzymes Plasma proteins
| | | | | Tissue enhanced |
ALPL | Alkaline phosphatase, liver/bone/kidney | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ALX1 | ALX homeobox 1 | Disease related genes Transcription factors
| | | | | Tissue enhanced |
ARSF | Arylsulfatase F | Predicted membrane proteins
| | | | | Tissue enhanced |
ASPA | Aspartoacylase | Disease related genes Enzymes Potential drug targets
| | | | | Tissue enhanced |
ASS1 | Argininosuccinate synthase 1 | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Tissue enhanced |
ATP6V1B1 | ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1 | Disease related genes
| | | | | Tissue enhanced |
BBOX1 | Butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1 | Enzymes
| | | | | Tissue enhanced |
BICC1 | Bicaudal C homolog 1 (Drosophila) | Disease related genes
| | | | | Tissue enhanced |
CA12 | Carbonic anhydrase XII | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Tissue enhanced |
CASR | Calcium-sensing receptor | Disease related genes FDA approved drug targets G-protein coupled receptors Plasma proteins Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
CCDC64 | Coiled-coil domain containing 64 | Predicted membrane proteins
| | | | | Tissue enhanced |
CDH6 | Cadherin 6, type 2, K-cadherin (fetal kidney) | Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CGNL1 | Cingulin-like 1 | Disease related genes
| | | | | Tissue enhanced |
CHDH | Choline dehydrogenase | Enzymes Mitochondrial proteins
| | | | | Tissue enhanced |
CLDN10 | Claudin 10 | Predicted membrane proteins
| | | | | Tissue enhanced |
CLDN2 | Claudin 2 | Predicted membrane proteins
| | | | | Tissue enhanced |
CLNK | Cytokine-dependent hematopoietic cell linker | | | | | | Tissue enhanced |
CRB2 | Crumbs homolog 2 (Drosophila) | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
DCDC2 | Doublecortin domain containing 2 | Disease related genes Plasma proteins
| | | | | Tissue enhanced |
DDC | Dopa decarboxylase (aromatic L-amino acid decarboxylase) | Disease related genes Enzymes FDA approved drug targets
| | | | | Tissue enhanced |
DPEP1 | Dipeptidase 1 (renal) | Enzymes FDA approved drug targets Predicted secreted proteins
| | | | | Tissue enhanced |
EFHD1 | EF-hand domain family, member D1 | | | | | | Tissue enhanced |
EXOC3L2 | Exocyst complex component 3-like 2 | | | | | | Tissue enhanced |
FLRT3 | Fibronectin leucine rich transmembrane protein 3 | Disease related genes Predicted membrane proteins
| | | | | Tissue enhanced |
GGT1 | Gamma-glutamyltransferase 1 | Candidate cardiovascular disease genes CD markers Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
GGT2 | Gamma-glutamyltransferase 2 | Predicted membrane proteins
| | | | | Tissue enhanced |
GGTLC2 | Gamma-glutamyltransferase light chain 2 | | | | | | Tissue enhanced |
GSTA1 | Glutathione S-transferase alpha 1 | Enzymes Plasma proteins
| | | | | Tissue enhanced |
GSTA2 | Glutathione S-transferase alpha 2 | Enzymes
| | | | | Tissue enhanced |
HNF1A | HNF1 homeobox A | Cancer-related genes Disease related genes Transcription factors
| | | | | Tissue enhanced |
HNF1B | HNF1 homeobox B | Disease related genes Transcription factors
| | | | | Tissue enhanced |
HOXA9 | Homeobox A9 | Cancer-related genes Disease related genes Plasma proteins Transcription factors
| | | | | Tissue enhanced |
HOXC10 | Homeobox C10 | Transcription factors
| | | | | Tissue enhanced |
HSD11B2 | Hydroxysteroid (11-beta) dehydrogenase 2 | Disease related genes Predicted membrane proteins
| | | | | Tissue enhanced |
IL17RB | Interleukin 17 receptor B | Predicted membrane proteins
| | | | | Tissue enhanced |
IRX1 | Iroquois homeobox 1 | Plasma proteins Transcription factors
| | | | | Tissue enhanced |
KCNJ15 | Potassium inwardly-rectifying channel, subfamily J, member 15 | Predicted membrane proteins Voltage-gated ion channels
| | | | | Tissue enhanced |
LIME1 | Lck interacting transmembrane adaptor 1 | Predicted secreted proteins
| | | | | Tissue enhanced |
LRP2 | Low density lipoprotein receptor-related protein 2 | Disease related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
MME | Membrane metallo-endopeptidase | Cancer-related genes Candidate cardiovascular disease genes CD markers Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
NPHS1 | Nephrosis 1, congenital, Finnish type (nephrin) | Disease related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
OGDHL | Oxoglutarate dehydrogenase-like | Citric acid cycle related proteins Mitochondrial proteins
| | | | | Tissue enhanced |
PAH | Phenylalanine hydroxylase | Disease related genes Enzymes FDA approved drug targets
| | | | | Tissue enhanced |
PALM3 | Paralemmin 3 | | | | | | Tissue enhanced |
PARD6B | Par-6 family cell polarity regulator beta | | | | | | Tissue enhanced |